3 completed, 1 suspended, 1 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Suspended 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow STEBA France: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers S-Tenatoprazole-Na (STU-Na) - Esophagitis, Gastroesophageal Reflux | Phase 1 | Completed | STEBA France | 32 | 2006-09-01 | 2008-03-24 |
| Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy Treatment with WST09 Vascular Photodynamic therapy - Prostate Cancer | Phase 2 / Phase 3 | Terminated | STEBA France | 16 | 2006-05-01 | 2010-06-02 |
| Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure Treatment with Tookad VTP - Prostate Cancer | Phase 2 | Completed | STEBA France | 8 | 2006-03-01 | 2010-06-02 |
| Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis S-Tenatoprazole-Na (STU-Na) - Esophagitis, Reflux | Phase 2 | Suspended | STEBA France | 450 | 2006-02-01 | 2008-03-19 |
| Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy WST09 - Recurrent or Persistent Localized Carcinoma of the Prostate Following Radiation Therapy Failure | Phase 2 | Completed | STEBA France | 28 | 2004-04-01 | 2010-06-22 |
Prostatic Neoplasms (2) · Duodenal Ulcer (1) · Esophagitis (1) · Esophagitis, Peptic (1) · Gastroesophageal Reflux (1) · Heartburn (1) · Recurrence (1) · Stomach Ulcer (1)
Therapeutics (2)
Canada (4) · United States (1)
Alan Thomson, MD, Prof. (1) · Christof Kreutz, MD (1) · Dennis A Ruff, MD (1) · John Trachtenberg, MD (1) · John Trachtenberg, MD FRCS(C) (1) · John Trachtenberg, MD, FRCS(C) (1) · Patrick Cohen, MD (1)